Implications for Malawi Medicines Policy/Procurement/Production

Slides:



Advertisements
Similar presentations
Storage & distribution Challenges of Malaria drugs Presentation by Rémy Prohom RBM Partnership Secretariat, Malaria Medicines & Supplies Services Copenhagen.
Advertisements

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Strategies for Working with Countries – Regional and Sub-Regional Perspective and Experiences Essential Drugs and Medicines Policy WHO South-East Asia.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
PSM landscape, IHP+ June 2014, Geneva 1 |1 | Procurement and Supply Management Landscape of existing investments and priorities Lisa Hedman Department.
Zambia Pharmacovigilance Action Plan National Plan Revision Proposal Dr Albert Mwango Mrs Bernice MwaleSeptember 2004.
Progress on implementation of Pharmacovigilance in the NATIONAL ARV PROGRAMME November 2009 Dr Mwango A National ARV Programme Coordinator, Ministry of.
Public health, innovation and intellectual property 1 |1 | WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Global Strategy and Plan.
Workshop on Medicines Regulation in the Caribbean Barbados, September 8-9, 2009 Essential Regulatory Functions: Quality Assurance The CRDTL Experience.
Public Health, Innovation and Intellectual Property Improving access to medicines through local production: Some New Development I P C Meeting, Copenhagen.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
Procurement and Supply Management in Moldova Laurentiu IONESII.
National Medicine Policy
Monitoring Drug and Commodity Supply Chains for ARV Programmes Yasmin Chandani John Snow Inc/DELIVER.
The South African perspective
Wilbert Bannenberg SARPAM
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
Sustainable Approaches to Opening Access to Medical Inventions James Love Wizards of OS Berlin 15 Sept 06.
ACCESS TO MEDICINES - POLICY AND ISSUES
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
Zambia’s Porous Borders & the Influx of Medicines.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Promoting Drug and Therapeutics Committees in the Developing World
FIFTH MEETING OF HEALTH TEAM IHP+ COUNTRIES 2 – 5 December 2014, Siem Reap, Cambodia SESSION 7c) Managing Purchasing and Stock in Guinea-Bissau Current.
Dr Shanthi Pal Quality Assurance and Safety of Medicines WHO
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Group 2 GROUP 2. Outline Who are the stakeholders How do we create awareness Accessibility How do we promote R&D.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Minimum requirements for Pharmacovigilance in countries.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Single Competency Framework for Prescribers National Prescribing Centre (2012)
Pharmaceutical Working Group Working Group on Pharmaceuticals Key Points for Advocacy and Action.
Wilbert Bannenberg & Elodie Brandamir Technical & Operational Directors MeTA International Secretariat MeTA Kyrgyzstan Forum Bishkek, 16 April 2009 Medicines.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
1 PHARMACOVIGILANCE & THE NATIONAL ADVERSE DRUG REACTION (ADR) REPORTING SYSTEM Sarah Spiteri Post-Licensing Directorate Medicines Authority.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Zambia’s Country Experiences
Overview of the EAC Pharmacovigilance and Post-Marketing Surveillance Systems 1ST International High Level Multi-Stakeholder Conference Nairobi, 2-4.
Wilbert Bannenberg SARPAM
WHO Medicines Work in Countries: The Kenya Example
Malaria Programmes and Implication on Strengthening the overall Health System Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines.
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Unit 11 The Role of Public Health in HCS Unit 11 The Role of Public Health in Health and Social Care Aim The aim of this unit is to raise learners' awareness.
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
Richard Laing EMP/WHO TBS 2012
Developing pharmacovigilance: new challenges and opportunities Mary Couper and Shanthi Pal Quality Assurance and Safety of Medicines.
Helen Lee, European Commission
National Procurement Policies and access to medicines
How to promote access to medicines in Zimbabwe
Access to HIV/AIDS Medicines The 3x5 strategy
Essential Drugs and Medicines Policy (EDM) World Health Organization
National Medicines Policies
Medicines Safety Mary R. Couper
Stop Stock-outs Campaign in Uganda
Richard Laing WHO/PAU TBS 2013
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Group 5 Strengthening health services at District level (Referral pathways, capacity building, training & support, Coordination of stakeholders) Members;
Quality Assurance and Safety of Medicines
Essentials Policy Protocols Training Technical Mentorship
Zambia’s Country Experiences
National Medicines Policies
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Multisectoral Response
Presentation transcript:

Implications for Malawi Medicines Policy/Procurement/Production

GENERAL 1. Harmonize all affected policies National medicines policy Procurement policy Intellectual property

NM POLICY AREAS AFFECTED 2. LOCAL PRODUCTION Awareness of TRIPS Current capacity to be improved New investors to be encouraged (incentives)

POLICY AREAS AFFECTED 3. PROCUREMENT AND USE Monitoring and evaluation of supply chain Revive community drug receipt committees at district and health centre levels Rolling out the role of CSOs e.g Tendai project to monitor medicine use at community.

POLICY AREAS AFFECTED 4. TECHNICAL COOPERATION Include inter agency committee to include: ODDP, S&T, RG Public-Private partnerships

OTHER AREAS TO INCLUDE IN POLICY Pharmacovigilance: Vigilance and surveillance of ADRS of ART, resistance Pharmaceutical governance Accountability in selection, procurement, distribution and use

Intellectual Property Rights Policy Recognize issues captured in specific medicine policy areas that affect access to essential medicines